Back

Validation of a madit-ii derived, primary prevention mortality risk score after implantable cardioverter-defibrillator implantation

18 June 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Sudden cardiac death and implantable defibrillators Primary prevention (Sudden cardiac death and implantable defibrillators) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Juan Acosta Martinez

UNIVERSITY HOSPITAL VIRGEN DEL ROCIO, Seville (Spain)

13 More presentations in this session

Presentation thumbnail
Which is the benefit of ICD in patients with ischemic cardiomyopathy compare with those with idiopathic dilated cardiomyopathy, from DANISH trial to real life.
Doctor A. Tronconi (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Clinical outcomes after implantable cardioverter-defibrillator implantation: does gender matter? a propensity score analysis
Doctor J. Acosta Martinez (Seville, ES)
Abstract
Presentation thumbnail
Are implantable defibrillators less useful in patients with non-ischemic heart disease?
Doctor A. Marinheiro (Setubal, PT)
Abstract
Presentation thumbnail
Survival analysis in patients with and without implantable cardioverter defibrillator for primary prevention indication: a single-centre multiethnic experience
Miss A. Ayemon (Southampton, GB)
Abstract Slides
Presentation thumbnail
Postextrasystolic blood pressure potentiation is associated with appropriate device therapy and mortality in implantable cardioverter defibrillator recipients with a reduced LVEF
Miss A. van der Lingen (Amsterdam, NL)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Sudden cardiac death and implantable defibrillators

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources